ADGMAdagio Medical Holdings Inc.
ADGM
Adagio Medical Holdings Inc.571
Mkt Cap
$22.88MVolume
93,438.0052W High
$2.5852W Low
$0.74PE Ratio
-0.62ADGM Fundamentals
Price
$1.03Prev Close
$0.9003Open
$0.8650D MA
$1.17Beta
0.17Avg. Volume
227,881.06EPS (Annual)
-$1.51P/B
1.84Rev/Employee
$0.00$21.89
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management...
Business Wire·4d ago
Adagio Medical Announces Positive Pivotal Results for vCLAS Ventricular Ablation System
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported six month results...
Business Wire·6d ago
Adagio Medicals ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that its...
Business Wire·17d ago
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS Ventricular Ablation System
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to...
Business Wire·25d ago
Adagio Medical to Participate in the 25th Annual Needham Virtual Conference
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management...
Business Wire·27d ago
Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the pivotal...
Business Wire·1mo ago
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the fourth quarter ended December 31, 2025. Fourth Quarter and Recent Business Highlights...
Business Wire·1mo ago
Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication...
Business Wire·1mo ago
Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS System, Including Patients with Premature Ventricular Contractions (PVC)
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful...
Business Wire·1mo ago
Adagio Medical to Participate in the 38th Annual Roth Conference
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management...
Business Wire·2mo ago
<
1
2
...
>